Company profile FRLN
After 39 days of this quarter the interest is at 37.0. Based on that we can calculate that during remaining 52 days it will total up to 86.0. Freeline Therapeutics expected interest is significantly higher compared to same quarter last year (+681.8%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 33 | 54 63.6% QoQ | 39 -27.8% QoQ | 0 -100.0% QoQ |
| 2020 | 102 209.1% YoY inf% QoQ | 68 25.9% YoY -33.3% QoQ | 241 517.9% YoY 254.4% QoQ | 56 inf% YoY -76.8% QoQ |
| 2021 | 75 -26.5% YoY 33.9% QoQ | 139 104.4% YoY 85.3% QoQ | 259 7.5% YoY 86.3% QoQ | 104 85.7% YoY -59.8% QoQ |
| 2022 | 121 61.3% YoY 16.3% QoQ | 103 -25.9% YoY -14.9% QoQ | 82 -68.3% YoY -20.4% QoQ | 56 -46.2% YoY -31.7% QoQ |
| 2023 | 11 -90.9% YoY -80.4% QoQ | 116 12.6% YoY 954.5% QoQ | 151 84.1% YoY 30.2% QoQ | 79 41.1% YoY -47.7% QoQ |
| 2024 | 37 236.4% YoY -53.2% QoQ | - | - | - |
The average 5 years interest of Freeline Therapeutics was 7.38 per week. The last year interest of Freeline Therapeutics compared to the last 5 years has changed by 2.71%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 181.78%.
There is not enough data for Freeline Therapeutics gene therapy to provide analysis
There is not enough data for Freeline Therapeutics gene therapy to provide correlation calculation
There is not enough data for Freeline Therapeutics gene therapy to provide analysis
There is not enough data for Freeline Therapeutics hemophilia B to provide analysis
There is not enough data for Freeline Therapeutics hemophilia B to provide correlation calculation
There is not enough data for Freeline Therapeutics hemophilia B to provide analysis
There is not enough data for Freeline Therapeutics Gaucher disease to provide analysis
There is not enough data for Freeline Therapeutics Gaucher disease to provide correlation calculation
There is not enough data for Freeline Therapeutics Gaucher disease to provide analysis
There is not enough data for Freeline Therapeutics Fabry disease to provide analysis
There is not enough data for Freeline Therapeutics Fabry disease to provide correlation calculation
There is not enough data for Freeline Therapeutics Fabry disease to provide analysis
There is not enough data for Freeline Therapeutics gene therapy research to provide analysis
There is not enough data for Freeline Therapeutics gene therapy research to provide correlation calculation
There is not enough data for Freeline Therapeutics gene therapy research to provide analysis
There is not enough data for Freeline Therapeutics clinical trials to provide analysis
There is not enough data for Freeline Therapeutics clinical trials to provide correlation calculation
There is not enough data for Freeline Therapeutics clinical trials to provide analysis
After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0. Freeline Therapeutics stock expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 68 | 117 72.1% QoQ | 129 10.3% QoQ | 0 -100.0% QoQ |
| 2020 | 48 -29.4% YoY inf% QoQ | 77 -34.2% YoY 60.4% QoQ | 126 -2.3% YoY 63.6% QoQ | 17 inf% YoY -86.5% QoQ |
| 2021 | 113 135.4% YoY 564.7% QoQ | 59 -23.4% YoY -47.8% QoQ | 263 108.7% YoY 345.8% QoQ | 75 341.2% YoY -71.5% QoQ |
| 2022 | 77 -31.9% YoY 2.7% QoQ | 55 -6.8% YoY -28.6% QoQ | 35 -86.7% YoY -36.4% QoQ | 49 -34.7% YoY 40.0% QoQ |
| 2023 | 53 -31.2% YoY 8.2% QoQ | 61 10.9% YoY 15.1% QoQ | 83 137.1% YoY 36.1% QoQ | 74 51.0% YoY -10.8% QoQ |
| 2024 | 0 -100.0% YoY -100.0% QoQ | - | - | - |
The average 5 years interest of Freeline Therapeutics stock was 6.05 per week. The last year interest of Freeline Therapeutics stock compared to the last 5 years has changed by -13.88%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -18.21%.
There is not enough data for Freeline Therapeutics careers to provide analysis
There is not enough data for Freeline Therapeutics careers to provide correlation calculation
There is not enough data for Freeline Therapeutics careers to provide analysis
There is not enough data for Freeline Therapeutics contact to provide analysis
There is not enough data for Freeline Therapeutics contact to provide correlation calculation
There is not enough data for Freeline Therapeutics contact to provide analysis